MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

10 Feb 2025 Evaluate
The company witnessed a 7.23% growth in the revenue at Rs. 88.22 millions for the quarter ended December 2024 as compared to Rs. 82.27 millions during the year-ago period.A humble growth in net profit of 5.06% reported in the quarter ended December 2024 to Rs. 14.53  millions from Rs. 13.83 millions.Operating profit for the quarter ended December 2024 rose to 21.09 millions as compared to 19.55 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 88.22 82.27 7.23 262.35 258.80 1.37 370.18 379.41 -2.43
Other Income 5.40 5.02 7.57 15.18 11.97 26.82 19.41 22.98 -15.54
PBIDT 21.09 19.55 7.88 55.57 53.19 4.47 83.33 78.06 6.75
Interest 0.57 0.09 533.33 1.89 1.00 89.00 2.64 1.31 101.53
PBDT 20.52 19.46 5.45 53.68 52.19 2.85 80.69 76.75 5.13
Depreciation 0.88 0.78 12.82 2.59 1.83 41.53 1.74 2.00 -13.00
PBT 19.64 18.68 5.14 51.09 50.36 1.45 78.95 74.75 5.62
TAX 5.11 4.85 5.36 13.29 13.09 1.53 20.36 18.85 8.01
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.48 -0.02 -2500.00
PAT 14.53 13.83 5.06 37.80 37.27 1.42 58.59 55.90 4.81
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 23.91 23.76 0.60 21.18 20.55 3.06 22.51 20.57 9.41
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..